Client News

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Advanced Medical Balloons Presents Results from HYDRA-PMCF Study of hygh-tec®, Demonstrating High Performance and Safety

Galimedix Therapeutics Presents further Scientific Data Showing Disease-modifying Potential of Oral GAL-201 in Alzheimer’s Disease as well as Beneficial Effects on Synaptic Function and Neuroimmunomodulation at AD/PD™ 2025

Newron Presents 2024 Financial Results and Provides 2025 Outlook

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

AFYREN Announces its 2024 Full-Year Financial Results

Formycon Reports on a Successful Financial Year 2024 with Strong Operational Progress and Continuous Strengthening of its Market Position

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

Secarna Pharmaceuticals to Present Positive New Data on Antisense Oligonucleotide SECN-15 Targeting NRP1 as Monotherapy and in Combination with Immune Checkpoint Inhibitors at AACR

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025